Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Harvard Apparatus Regenerative Technology, Inc. (HRGN) had Income from Continuous Operations of $-1.70M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.12M |
|
$-1.70M |
|
$0.11M |
|
$0.01M |
|
$1.84M |
|
$-1.71M |
|
$0.03M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
|
Income from Continuous Operations |
$-1.70M |
$-1.70M |
|
$-1.70M |
|
$-1.71M |
|
$-1.69M |
|
17.03M |
|
17.03M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$1.63M |
|
$0.01M |
|
$0.92M |
|
$2.55M |
|
$0.88M |
|
-- |
|
$0.12M |
|
$0.99M |
|
$1.55M |
|
$1.55M |
|
$1.55M |
|
17.17M |
|
| Cash Flow Statement Financials | |
$-3.16M |
|
-- |
|
$2.00M |
|
$2.49M |
|
$1.32M |
|
$-1.17M |
|
$1.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
8.94% |
|
-1393.50% |
|
-1393.50% |
|
-- |
|
-1382.11% |
|
-1382.11% |
|
$-3.16M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
5.09 |
|
41.00 |
|
2.20 |
|
-109.40% |
|
-109.40% |
|
-66.77% |
|
-109.40% |
|
$0.09 |
|
$-0.19 |
|
$-0.19 |
|